Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  More, Sandeep Vasant ^a   Kumar, Hemant ^a   Kang, Seong Mook ^a   Song, Soo Yeol ^a   Lee, Kippeum ^a   Choi, Dong Kug ^a  

^a Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACACETIN; ACTEOSIDE; ASIATICOSIDE; ASTRAGALOSIDE IV; BAICALEIN; CURCUMIN; ECHINACOSIDE; ESCULETIN; FUCOIDIN; GASTRODIN; GINSENOSIDE RG 1; HERBACEOUS AGENT; LUTEOLIN; MAGNOLOL; MORIN; NAPHTHAZARIN; PAEONIFLORIN; PROTOCATECHUIC ACID; PUERARIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; S ALLYLCYSTEINE; SAPONIN; TENUIGENIN; TETRAMETHYLPYRAZINE; THEAFLAVIN; UMBELLIFERONE; UNCLASSIFIED DRUG; XYLOKETAL B;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL SURVIVAL; CELL VIABILITY; CHAPERONE-MEDIATED AUTOPHAGY; CISTANCHE; CURCUMA LONGA; DOPAMINERGIC NERVE CELL; DRUG STRUCTURE; GASTRODIA ELATA; GENE EXPRESSION; GINSENG; HEART PROTECTION; HERBAL MEDICINE; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PAEONIA LACTIFLORA; PANAX NOTOGINSENG; PARKINSON DISEASE; POLYGALA TENUIFOLIA; POLYGALACEAE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERARIA LOBATA; SCUTELLARIA BAICALENSIS; TREATMENT DURATION; UPREGULATION; VELVET BEAN;

EID: 84885350806     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/957875     Document Type: Article

References (116)

1. Liu S.-M., Li X.-Z., Huo Y., Lu F., Protective effect of extract of Acanthopanax senticosus harms on dopaminergic neurons in Parkinson's disease mice. Phytomedicine 2012 19 631 638 2-s2.0-84857664991 10.1016/j.phymed.2012.02. 006
2. Schapira A. H. V., Bezard E., Brotchie J., Calon F., Collingridge G. L., Ferger B., Hengerer B., Hirsch E., Jenner P., Novère N. L., Obeso J. A., Schwarzschild M. A., Spampinato U., Davidai G., Novel pharmacological targets for the treatment of Parkinson's disease. Nature Reviews Drug Discovery 2006 5 10 845 854 2-s2.0-33749247103 10.1038/nrd2087 (Pubitemid 44480538)
3. Singh S., Dikshit M., Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide. Brain Research Reviews 2007 54 2 233 250 2-s2.0-34250016055 10.1016/j.brainresrev.2007.02.001 (Pubitemid 46891075)
4. More S. V., Kumar H., Kim I. S., Koppulla S., Kim B. W., Choi D. K., Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies. CNS & Neurological Disorders Drug Targets 2013 12 5 680 697
5. Cannon J. R., Greenamyre J. T., Neurotoxic in vivo models of Parkinson's disease. Recent advances. Progress in Brain Research 2010 184 17 33 2-s2.0-77957239234 10.1016/S0079-6123(10)84002-6
6. Fox S. H., Brotchie J. M., The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. Progress in Brain Research 2010 184 133 157 2-s2.0-77955402231 10.1016/S0079-6123(10)84007-5
7. Manyam B. V., Sánchez-Ramos J. R., Traditional and complementary therapies in Parkinson's disease. Advances in Neurology 1999 80 565 574 2-s2.0-0032617187
8. Manyam B. V., Paralysis agitans and levodopa in 'Ayurveda': ancient Indian medical treatise. Movement Disorders 1990 5 1 47 48 2-s2.0-0025373513 (Pubitemid 20110868)
9. Lieu C. A., Kunselman A. R., Manyam B. V., Venkiteswaran K., Subramanian T., A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism and Related Disorders 2010 16 7 458 465 2-s2.0-77954952694 10.1016/j.parkreldis.2010.04.015
10. Manyam B. V., Dhanasekaran M., Hare T. A., Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Phytotherapy Research 2004 18 9 706 712 2-s2.0-8344282763 10.1002/ptr.1514 (Pubitemid 39481688)
11. Katzenshlager R., Evans A., Manson A., Palsalos P. N., Ratnaraj N., Watt H., Timmermann L., Van Der Giessen R., Lees A. J., Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery and Psychiatry 2004 75 12 1672 1677 2-s2.0-10044247488 10.1136/jnnp.2003.028761 (Pubitemid 39611463)
12. Song J.-X., Sze S. C.-W., Ng T.-B., Lee C. K.-F., Leung G. P. H., Shaw P.-C., Tong Y., Zhang Y.-B., Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? Journal of Ethnopharmacology 2012 139 3 698 711 2-s2.0-84856225515 10.1016/j.jep.2011.12.030
13. Li X. Z., Zhang S. N., Liu S. M., Lu F., Recent advances in herbal medicines treating Parkinson's disease. Fitoterapia 2013 84 273 285
14. Chung V., Liu L., Bian Z., Zhao Z., Fong W. L., Kum W. F., Gao J., Li M., Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review. Movement Disorders 2006 21 10 1709 1715 2-s2.0-33750987900 10.1002/mds.21008 (Pubitemid 44742202)
15. Kumar G. P., Khanum F., Neuroprotective potential of phytochemicals. Pharmacognosy Reviews 2012 6 81 90
16. Lobo V., Patil A., Phatak A., Chandra N., Free radicals, antioxidants and functional foods: impact on human health. Pharmacognosy Reviews 2010 4 8 118 126 2-s2.0-78651391894 10.4103/0973-7847.70902
17. Li Q., Zhao D., Bezard E., Traditional Chinese medicine for Parkinson's disease: a review of Chinese literature. Behavioural Pharmacology 2006 17 5-6 403 410 2-s2.0-33748305732 10.1097/00008877-200609000-00006 (Pubitemid 44325802)
18. Ip P. S., Tsim K. W., Chan K., Bauer R., Application of complementary and alternative medicine on neurodegenerative disorders: current status and future prospects. Evidence-Based Complementary and Alternative Medicine 2012 2012 2 930908 10.1155/2012/930908
19. Saklani A., Kutty S. K., Plant-derived compounds in clinical trials. Drug Discovery Today 2008 13 3-4 161 171 2-s2.0-39149137869 10.1016/j.drudis.2007. 10.010
20. +)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells. Journal of Ethnopharmacology 2011 135 1 34 42 2-s2.0-79955473944 10.1016/j.jep.2011.02.017
21. Radad K., Gille G., Moldzio R., Saito H., Rausch W.-D., Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Research 2004 1021 1 41 53 2-s2.0-4344622460 10.1016/j.brainres.2004.06. 030 (Pubitemid 39158655)
22. Luo F.-C., Wang S.-D., Li K., Nakamura H., Yodoi J., Bai J., Panaxatriol saponins extracted from Panax notoginseng induces thioredoxin-1 and prevents 1-methyl-4-phenylpyridinium ion-induced neurotoxicity. Journal of Ethnopharmacology 2010 127 2 419 423 2-s2.0-73749086765 10.1016/j.jep.2009.10. 023
23. Luo F.-C., Wang S.-D., Qi L., Song J.-Y., Lv T., Bai J., Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo. Journal of Ethnopharmacology 2011 133 2 448 453 2-s2.0-78651402013 10.1016/j.jep.2010.10.017
24. Liu Q., Kou J.-P., Yu B.-Y., Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF- B activation. Neurochemistry International 2011 58 1 119 125 2-s2.0-78650415275 10.1016/j.neuint.2010.11.004
25. Xu H., Jiang H., Wang J., Xie J., Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells. Journal of Cellular Biochemistry 2010 111 6 1537 1545 2-s2.0-78649782421 10.1002/jcb.22885
26. +-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake. Neuropharmacology 2010 58 2 488 494 2-s2.0-72049117894 10.1016/j.neuropharm.2009.09.002
27. Wang J., Xu H.-M., Yang H.-D., Du X.-X., Jiang H., Xie J.-X., Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochemistry International 2009 54 1 43 48 2-s2.0-59049094805 10.1016/j.neuint.2008.10.003
28. Hu J.-F., Song X.-Y., Chu S.-F., Chen J., Ji H.-J., Chen X.-Y., Yuan Y.-H., Han N., Zhang J.-T., Chen N.-H., Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice. Brain Research 2011 1374 8 14 2-s2.0-79251622569 10.1016/j.brainres.2010.11.069
29. Xu L., Liu L. X., Chen W. F., Xie J. X., Huang W. X., The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2008 24 1 5
30. Xu L., Chen W.-F., Wong M.-S., Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway. British Journal of Pharmacology 2009 158 3 738 748 2-s2.0-70350062072 10.1111/j.1476-5381.2009.00361.x
31. Jeong K., Shin Y.-C., Park S., Park J.-S., Kim N., Um J.-Y., Go H., Sun S., Lee S., Park W., Choi Y., Song Y., Kim G., Jeon C., Park J., Lee K., Bang O., Ko S.-G., Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice. Journal of Biomedical Science 2011 18 1, article 14 2-s2.0-79551681325 10.1186/1423-0127-18-14
32. Li X.-X., He G.-R., Mu X., Xu B., Tian S., Yu X., Meng F.-R., Xuan Z.-H., Du G.-H., Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria. European Journal of Pharmacology 2012 674 2-3 227 233 2-s2.0-84855525812 10.1016/j.ejphar.2011.09.181
33. Mu X., He G., Cheng Y., Li X., Xu B., Du G., Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacology Biochemistry and Behavior 2009 92 4 642 648 2-s2.0-67349270928 10.1016/j.pbb.2009.03.008
34. Yu X., He G. R., Sun L., Lan X., Shi L. L., Xuan Z. H., Du G. H., Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism. Life Sciences 2012 91 5 13
35. Mu X., He G.-R., Yuan X., Li X.-X., Du G.-H., Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacology Biochemistry and Behavior 2011 98 2 286 291 2-s2.0-79751527791 10.1016/j.pbb.2011.01.011
36. Cheng Y., He G., Mu X., Zhang T., Li X., Hu J., Xu B., Du G., Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neuroscience Letters 2008 441 1 16 20 2-s2.0-46149119392 10.1016/j.neulet.2008.05.116
37. Jiang M., Porat-Shliom Y., Pei Z., Cheng Y., Xiang L., Sommers K., Li Q., Gillardon F., Hengerer B., Berlinicke C., Smith W. W., Zack D. J., Poirier M. A., Ross C. A., Duan W., Baicalein reduces E46K α -synuclein aggregation in vitro and protects cells against E46K α -synuclein toxicity in cell models of familiar Parkinsonism. Journal of Neurochemistry 2010 114 2 419 429 2-s2.0-77953853289 10.1111/j.1471-4159.2010.06752.x
38. Lu J.-H., Ardah M. T., Durairajan S. S. K., Liu L.-F., Xie L.-X., Fong W.-F. D., Hasan M. Y., Huang J.-D., El-Agnaf O. M. A., Li M., Baicalein inhibits formation of alpha-synuclein oligomers within living cells and prevents Abeta peptide fibrillation and oligomerisation. ChemBioChem 2011 12 4 615 624 2-s2.0-79952010449 10.1002/cbic.201000604
39. Marchiani A., Rozzo C., Fadda A., Delogu G., Ruzza P., Curcumin and curcumin-like molecules: from spice to drugs. Current Medicinal Chemistry. In press
40. Gupta S. C., Patchva S., Koh W., Aggarwal B. B., Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clinical and Experimental Pharmacology and Physiology 2012 39 3 283 299 2-s2.0-84857417967 10.1111/j.1440-1681.2011.05648.x
41. Jiang T. F., Zhang Y. J., Zhou H. Y., Wang H. M., Tian L. P., Liu J., Ding J. Q., Chen S. D., Curcumin ameliorates the neurodegenerative pathology in A53T alpha-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. Journal of NeuroImmune Pharmacology 2013 8 356 369
42. Wang M. S., Boddapati S., Emadi S., Sierks M. R., Curcumin reduces α -synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neuroscience 2010 11, article 57 2-s2.0-77951557863 10.1186/1471-2202-11-57
43. Ojha R. P., Rastogi M., Devi B. P., Agrawal A., Dubey G. P., Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Journal of Neuroimmune Pharmacology 2012 7 609 618 2-s2.0-84859904788 10.1007/s11481-012-9363-2
44. Pan J., Li H., Ma J. F., Tan Y. Y., Xiao Q., Ding J. Q., Chen S. D., Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease through suppressing mitochondria dysfunction. Translational Neurodegeneration 2012 1 1 16
45. Tripanichkul W., Jaroensuppaperch E.-O., Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model. International Journal of Neuroscience 2012 122 5 263 270 2-s2.0-84859395842 10.3109/00207454.2011.648760
46. +-induced cytotoxicity in human dopaminergic SH-SY5Y cells. Journal of Ethnopharmacology 2010 130 2 290 298 2-s2.0-77954955677 10.1016/j.jep.2010.05.006
47. Kim I. S., Choi D.-K., Jung H. J., Neuroprotective effects of vanillyl alcohol in gastrodia elata blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells. Molecules 2011 16 7 5349 5361 2-s2.0-79960800502 10.3390/molecules16075349
48. Kumar H., Kim I. S., More S. V., Kim B. W., Bahk Y. Y., Choi D. K., Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model. Evidence-Based Complementary and Alternative Medicine 2013 2013 13 10.1155/2013/514095 514095
49. Dai J.-N., Zong Y., Zhong L.-M., Li Y.-M., Zhang W., Bian L.-G., Ai Q.-L., Liu Y.-D., Sun J., Lu D., Gastrodin inhibits expression of inducible no synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-Stimulated microglia via MAPK pathways. PLoS ONE 2011 6 7 2-s2.0-79960170945 10.1371/journal.pone.0021891 e21891
50. Frémont L., Biological effects of resveratrol. Life Sciences 2000 66 8 663 673 2-s2.0-0034645693 10.1016/S0024-3205(99)00410-5 (Pubitemid 30077860)
51. Bhat K. P. L., Kosmeder J. W. II, Pezzuto J. M., Biological effects of resveratrol. Antioxidants and Redox Signaling 2001 3 6 1041 1064 2-s2.0-0035663191 (Pubitemid 34027361)
52. Chang C. Y., Choi D. K., Lee D. K., Hong Y. J., Park E. J., Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cells. PLoS ONE 2013 8 e60654
53. Wu Y., Li X., Zhu J. X., Xie W., Le W., Fan Z., Jankovic J., Pan T., Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. NeuroSignals 2011 19 3 163 174 2-s2.0-80052359850 10.1159/000328516
54. +-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cellular and Molecular Neurobiology 2009 29 8 1169 1180 2-s2.0-77049122576 10.1007/s10571-009-9411-5
55. Alvira D., Yeste-Velasco M., Folch J., Verdaguer E., Canudas A. M., Pallàs M., Camins A., Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 2007 147 3 746 756 2-s2.0-34250860632 10.1016/j.neuroscience.2007.04.029 (Pubitemid 46990651)
56. Lu K.-T., Ko M.-C., Chen B.-Y., Huang J.-C., Hsieh C.-W., Lee M.-C., Chiou R. Y. Y., Wung B.-S., Peng C.-H., Yang Y.-L., Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. Journal of Agricultural and Food Chemistry 2008 56 16 6910 6913 2-s2.0-51649086475 10.1021/jf8007212
57. Srivastava G., Dixit A., Yadav S., Patel D. K., Prakash O., Singh M. P., Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radical Biology and Medicine 2012 52 8 1294 1306 2-s2.0-84857932521 10.1016/j.freeradbiomed.2012.02. 005
58. Jin F., Wu Q., Lu Y.-F., Gong Q.-H., Shi J.-S., Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. European Journal of Pharmacology 2008 600 1-3 78 82 2-s2.0-56149119401 10.1016/j.ejphar.2008.10.005
59. Khan M. M., Ahmad A., Ishrat T., Khan M. B., Hoda M. N., Khuwaja G., Raza S. S., Khan A., Javed H., Vaibhav K., Islam F., Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Research 2010 1328 139 151 2-s2.0-77950594327 10.1016/j.brainres.2010.02.031
60. Wang Y., Xu H., Fu Q., Ma R., Xiang J., Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats. Journal of the Neurological Sciences 2011 304 1-2 29 34 2-s2.0-79953321373 10.1016/j.jns.2011.02.025
61. Chao J., Li H., Cheng K.-W., Yu M.-S., Chang R. C.-C., Wang M., Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. Journal of Nutritional Biochemistry 2010 21 6 482 489 2-s2.0-77952882393 10.1016/j.jnutbio.2009.02.004
62. Li W.-W., Yang R., Cai D.-F., Protective effects of Cistanche total glycosides on dopaminergic neuron in substantia nigra of model mice of Parkinson's disease. Chinese Journal of Integrated Traditional and Western Medicine 2008 28 3 248 251 2-s2.0-58149359456
63. Gao Y., Pu X.-P., Neuroprotective effect of acteoside against rotenone-induced damage of SH-SY5Y cells and its possible mechanism. Chinese Pharmacological Bulletin 2007 23 2 161 165 2-s2.0-34247505547 (Pubitemid 46658020)
64. Lee J. Y., Woo E.-R., Kang K. W., Inhibition of lipopolysaccharide- inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. Journal of Ethnopharmacology 2005 97 3 561 566 2-s2.0-14644443518 10.1016/j.jep.2005.01.005 (Pubitemid 40312335)
65. Zhao L., Pu X.-P., Neuroprotective effect of acteoside against MPTP-induced mouse model of Parkinsons disease. Chinese Pharmacological Bulletin 2007 23 1 42 46 2-s2.0-34247505162 (Pubitemid 46657656)
66. Xie J., Deng J., Tan F., Su J., Separation and purification of echinacoside from Penstemon barbatus (Can.) Roth by recycling high-speed counter-current chromatography. Journal of Chromatography B 2010 878 28 2665 2668 2-s2.0-77957298628 10.1016/j.jchromb.2010.07.023
67. Chen H., Jing F. C., Li C. L., Tu P. F., Zheng Q. S., Wang Z. H., Echinacoside prevents the striatal extracellular levels of monoamine neurotransmitters from diminution in 6-hydroxydopamine lesion rats. Journal of Ethnopharmacology 2007 114 3 285 289 2-s2.0-35648956703 10.1016/j.jep.2007.07. 035 (Pubitemid 350026211)
68. Zhao X., Pu X.-P., Geng X.-C., Effects of echinacoside on protein expression from substantia nigra and striatal tissue in mouse MPTP model of Parkinsons disease by using 2-dimensional electrophoresis analysis. Chinese Pharmacological Bulletin 2008 24 1 28 32 2-s2.0-42549152344 (Pubitemid 351587340)
69. Geng X., Tian X., Tu P., Pu X., Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease. European Journal of Pharmacology 2007 564 1-3 66 74 2-s2.0-34250640707 10.1016/j.ejphar.2007.01.084 (Pubitemid 46946841)
70. Zhao Q., Gao J., Li W., Cai D., Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease. Brain Research 2010 1346 224 236 2-s2.0-77955514855 10.1016/j.brainres.2010.05.018
71. Liu H.-Q., Zhang W.-Y., Luo X.-T., Ye Y., Zhu X.-Z., Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. British Journal of Pharmacology 2006 148 3 314 325 2-s2.0-33744497031 10.1038/sj.bjp.0706732 (Pubitemid 43801179)
72. Liu D.-Z., Xie K.-Q., Ji X.-Q., Ye Y., Jiang C.-L., Zhu X.-Z., Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists. British Journal of Pharmacology 2005 146 4 604 611 2-s2.0-27144558321 10.1038/sj.bjp.0706335 (Pubitemid 41487077)
73. Liu D.-Z., Zhu J., Jin D.-Z., Zhang L.-M., Ji X.-Q., Ye Y., Tang C.-P., Zhu X.-Z., Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease. Journal of Ethnopharmacology 2007 112 2 327 332 2-s2.0-34248597746 10.1016/j.jep.2007.03. 022 (Pubitemid 46756082)
74. + and acidic damage via autophagic pathway. Journal of Ethnopharmacology 2010 131 1 122 129 2-s2.0-77955332763 10.1016/j.jep.2010.06. 009
75. Sun X., Cao Y.-B., Hu L.-F., Yang Y.-P., Li J., Wang F., Liu C.-F., ASICs mediate the modulatory effect by paeoniflorin on alpha-synuclein autophagic degradation. Brain Research 2011 1396 77 87 2-s2.0-79957735511 10.1016/j.brainres.2011.04.011
76. Jiang Y., Tu P.-F., Xanthone O-glycosides from Polygala tenuifolia. Phytochemistry 2002 60 8 813 816 2-s2.0-0036668384 10.1016/S0031-9422(02)00184-X
77. Jiang Y., Tu P., Four new phenones from the cortexes of Polygala tenuifolia. Chemical and Pharmaceutical Bulletin 2005 53 9 1164 1166 2-s2.0-24944499179 10.1248/cpb.53.1164 (Pubitemid 41330482)
78. Jiang Y., Zhang W., Tu P., Xu X., Xanthone glycosides from Polygala tenuifolia and their conformational analyses. Journal of Natural Products 2005 68 6 875 879 2-s2.0-22544474151 10.1021/np050026+ (Pubitemid 41017500)
79. Yan M., Studies on antiaging action of Polygala tenuifolia Wild. Journal of Clinical Pharmacy and Therapeutics 2006 6
80. Zhang H., Han T., Zhang L., Yu C.-H., Wan D.-G., Rahman K., Qin L.-P., Peng C., Effects of tenuifolin extracted from radix polygalae on learning and memory: a behavioral and biochemical study on aged and amnesic mice. Phytomedicine 2008 15 8 587 594 2-s2.0-46149083737 10.1016/j.phymed.2007.12.004
81. Choi J. G., Kim H. G., Kim M. C., Yang W. M., Huh Y., Kim S. Y., Oh M. S., Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models. Journal of Ethnopharmacology 2011 134 2 414 421 2-s2.0-79952697907 10.1016/j.jep.2010.12.030
82. Liang Z., Shi F., Wang Y., Lu L., Zhang Z., Wang X., Wang X., Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury. Neuroscience Letters 2011 497 2 104 109 2-s2.0-79956333078 10.1016/j.neulet.2011.04.041
83. Yuan H. L., Li B., Xu J., Wang Y., He Y., Zheng Y., Wang X. M., Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide. CNS Neuroscience & Therapeutics 2012 18 584 590
84. Chang Y., Hsieh C.-Y., Peng Z.-A., Yen T.-L., Hsiao G., Chou D.-S., Chen C.-M., Sheu J.-R., Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats. Journal of Biomedical Science 2009 16 1, article 9 2-s2.0-63449119215 10.1186/1423-0127-16-9
85. Han R.-M., Tian Y.-X., Becker E. M., Andersen M. L., Zhang J.-P., Skibsted L. H., Puerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with β -carotene. Journal of Agricultural and Food Chemistry 2007 55 6 2384 2391 2-s2.0-34147107123 10.1021/jf062796c (Pubitemid 46556228)
86. +-induced human neuroblastoma SH-SY5Y cell death. Neurochemistry International 2012 60 4 400 408 2-s2.0-84856999989 10.1016/j.neuint.2012.01.003
87. +-elicited apoptosis. Neuroscience Research 2009 63 1 52 58 2-s2.0-57649142972 10.1016/j.neures.2008.10.009
88. Li R., Zheng N., Liang T., He Q., Xu L., Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats. Brain Research 2013 1517 28 35
89. Zheng G.-M., Yu C., Yang Z., Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF- B translocation. International Journal of Oncology 2012 40 5 1610 1618 2-s2.0-84860310820 10.3892/ijo.2012.1331
90. +)-induced apoptosis in PC-12 cells. Neuroscience Letters 2011 487 1 88 93 2-s2.0-78650212384 10.1016/j.neulet.2010.10.002
91. Zhu G., Wang X., Chen Y., Yang S., Cheng H., Wang N., Li Q., Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Medica 2010 76 16 1820 1826 2-s2.0-78349270212 10.1055/s-0030-1249976
92. Zhang Z.-J., Cheang L. C. V., Wang M.-W., Li G.-H., Chu I. K., Lin Z.-X., Lee S. M. Y., Ethanolic extract of fructus alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Cellular and Molecular Neurobiology 2012 32 1 27 40 2-s2.0-84856534483 10.1007/s10571-011-9731-0
93. +-induced mitochondrial dysfunction and apoptotic cell death in PC12 cells. Food and Chemical Toxicology 2006 44 10 1659 1666 2-s2.0-33747043799 10.1016/j.fct.2006.05.004 (Pubitemid 44216075)
94. Zhang H.-N., An C.-N., Xu M., Guo D.-A., Li M., Pu X.-P., Protocatechuic acid inhibits rat pheochromocytoma cell damage induced by a dopaminergic neurotoxin. Biological and Pharmaceutical Bulletin 2009 32 11 1866 1869 2-s2.0-70350731121 10.1248/bpb.32.1866
95. Zhang H.-N., An C.-N., Zhang H.-N., Pu X.-P., Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo. Neuroscience Letters 2010 474 2 99 103 2-s2.0-77951207425 10.1016/j.neulet.2010.03.016
96. Subramaniam S. R., Ellis E. M., Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease. Journal of Neuroscience Research 2013 91 453 461
97. Xu C.-L., Wang Q.-Z., Sun L.-M., Li X.-M., Deng J.-M., Li L.-F., Zhang J., Xu R., Ma S.-P., Asiaticoside: attenuation of neurotoxicity induced by MPTP in a rat model of Parkinsonism via maintaining redox balance and up-regulating the ratio of Bcl-2/Bax. Pharmacology Biochemistry and Behavior 2012 100 3 413 418 2-s2.0-80054860012 10.1016/j.pbb.2011.09.014
98. Kim H. G., Ju M. S., Ha S. K., Lee H., Kim S. Y., Oh M. S., Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Biological & Pharmaceutical Bulletin 2012 35 1287 1294
99. Ha S. K., Moon E., Lee P., Ryu J. H., Oh M. S., Kim S. Y., Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo. Neurochemical Research 2012 37 1560 1567 2-s2.0-84858733352 10.1007/s11064-012-0751-z
100. +-Induced toxicity via Inhibition of oxidative stress in In vivo and In vitro models of parkinson's disease. Parkinson's Disease 2012 2012 9 10.1155/2012/985157 985157
101. Chen H.-H., Lin S.-C., Chan M.-H., Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism. Neurodegenerative Diseases 2011 8 5 364 374 2-s2.0-79958811068 10.1159/000323872
102. Chuang D. Y., Chan M. H., Zong Y., Sheng W., He Y., Jiang J. H., Simonyi A., Gu Z., Fritsche K. L., Cui J., Lee J. C., Folk W. R., Lubahn D. B., Sun A. Y., Sun G. Y., Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells. Journal of Neuroinflammation 2013 10 15
103. Choi S. Y., Son T. G., Park H. R., Jang Y. J., Oh S. B., Jin B., Lee J., Naphthazarin has a protective effect on the 1-methyl-4-phenyl-1,2,3,4- tetrahydropyridine-induced Parkinson's disease model. Journal of Neuroscience Research 2012 90 1842 1849 2-s2.0-84859872254 10.1002/jnr.23061
104. +-induced neurotoxicity in Caenorhabditis elegans and PC12 cells. Brain Research 2010 1332 110 119 2-s2.0-77951641666 10.1016/j.brainres. 2010.03.071
105. Zhang Z.-T., Cao X.-B., Xiong N., Wang H.-C., Huang J.-S., Sun S.-G., Wang T., Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo. Acta Pharmacologica Sinica 2010 31 8 900 906 2-s2.0-77955456603 10.1038/aps.2010.77
106. Luo D., Zhang Q., Wang H., Cui Y., Sun Z., Yang J., Zheng Y., Jia J., Yu F., Wang X., Wang X., Fucoidan protects against dopaminergic neuron death in vivo and in vitro. European Journal of Pharmacology 2009 617 1-3 33 40 2-s2.0-68549112705 10.1016/j.ejphar.2009.06.015
107. Cui Y. Q., Jia Y. J., Zhang T., Zhang Q. B., Wang X. M., Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia. CNS Neuroscience & Therapeutics 2012 18 827 833
108. Chen H.-Q., Jin Z.-Y., Wang X.-J., Xu X.-M., Deng L., Zhao J.-W., Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neuroscience Letters 2008 448 2 175 179 2-s2.0-56049116002 10.1016/j.neulet.2008.10.046
109. Du J., Shan L. C., Zhang G. X., Wang Y. Q., Effect of TMP on dopaminergic neuron injury induced by MPTP in vivo and vitro. Lishizhen Medicine and Materia Medica Research 2011 22 1564 1565
110. Liu H.-T., Du Y.-G., He J.-L., Chen W.-J., Li W.-M., Yang Z., Wang Y.-X., Yu C., Tetramethylpyrazine inhibits production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through blockade of MAPK and PI3K/Akt signaling pathways, and suppression of intracellular reactive oxygen species. Journal of Ethnopharmacology 2010 129 3 335 343 2-s2.0-77953355877 10.1016/j.jep.2010.03.037
111. +-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production. Molecular and Cellular Biochemistry 2012 364 209 216 2-s2.0-84856068806 10.1007/s11010-011-1219-1
112. Chan W.-S., Durairajan S. S. K., Lu J.-H., Wang Y., Xie L.-X., Kum W.-F., Koo I., Yung K. K. L., Li M., Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Neurochemistry International 2009 55 6 414 422 2-s2.0-67650064518 10.1016/j.neuint.2009.04.012
113. Anandhan A., Janakiraman U., Manivasagam T., Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease. Neuroscience 2012 218 257 267
114. Anandhan A., Tamilselvam K., Radhiga T., Rao S., Essa M. M., Manivasagam T., Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Research 2012 1433 104 113 2-s2.0-84855204111 10.1016/j.brainres.2011.11.021
115. García E., Villeda-Hernández J., Pedraza-Chaverrí J., Maldonado P. D., Santamaría A., S-allylcysteine reduces the MPTP-induced striatal cell damage via inhibition of pro-inflammatory cytokine tumor necrosis factor- α and inducible nitric oxide synthase expressions in mice. Phytomedicine 2010 18 1 65 73 2-s2.0-78049290874 10.1016/j.phymed.2010. 04.004
116. Rojas P., Serrano-García N., Medina-Campos O. N., Pedraza-Chaverri J., Maldonado P. D., Ruiz-Sánchez E., S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium- induced parkinsonism in mice. Journal of Nutritional Biochemistry 2011 22 10 937 944 2-s2.0-80053118896 10.1016/j.jnutbio.2010.08.005